Vekeman F - Search Results

1

Medical complications, resource utilization and costs in patients with myelofibrosis by frequency of blood transfusion and iron chelation therapy.

Vekeman F, Cheng WY, Sasane M, Huynh L, Duh MS, Paley C, Mesa RA. Vekeman F, et al. Leuk Lymphoma. 2015;56(10):2803-11. doi: 10.3109/10428194.2015.1016933. Epub 2015 Mar 30. Leuk Lymphoma. 2015. PMID: 25676036

2

Lifetime costs to Medicare of providing care to patients with chronic lymphocytic leukemia.

Lafeuille MH, Vekeman F, Wang ST, Kerrigan M, Menditto L, Duh MS. Lafeuille MH, et al. Among authors: vekeman f. Leuk Lymphoma. 2012 Jun;53(6):1146-54. doi: 10.3109/10428194.2011.643405. Epub 2012 Feb 3. Leuk Lymphoma. 2012. PMID: 22111902

3

Costs, resource utilization, and treatment patterns for patients with metastatic melanoma in a commercially insured setting.

Toy EL, Vekeman F, Lewis MC, Oglesby AK, Duh MS. Toy EL, et al. Among authors: vekeman f. Curr Med Res Opin. 2015 Aug;31(8):1561-72. doi: 10.1185/03007995.2015.1062356. Epub 2015 Jul 10. Curr Med Res Opin. 2015. PMID: 26086578

4

Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia.

Vekeman F, Sasane M, Cheng WY, Ramanakumar AV, Fortier J, Qiu Y, Duh MS, Paley C, Adams-Graves P. Vekeman F, et al. J Med Econ. 2016;19(3):292-303. doi: 10.3111/13696998.2015.1117979. Epub 2015 Nov 30. J Med Econ. 2016. PMID: 26618853 Free article.

5

Adherence to iron chelation therapy in patients who switched from deferasirox dispersible tablets to deferasirox film-coated tablets.

Cheng WY, Said Q, Hao Y, Xiao Y, Vekeman F, Bobbili P, Duh MS, Nandal S, Blinder M. Cheng WY, et al. Among authors: vekeman f. Curr Med Res Opin. 2018 Nov;34(11):1959-1966. doi: 10.1080/03007995.2018.1470500. Epub 2018 Jun 4. Curr Med Res Opin. 2018. PMID: 29701080

6

Drug utilisation and cost considerations of erythropoiesis stimulating agents in oncology patients receiving chemotherapy: observations from a large managed-care database.

Vekeman F, McKenzie RS, Bookhart BK, Laliberté F, Duh MS, Tak Piech C, Lefebvre P. Vekeman F, et al. J Med Econ. 2009 Mar;12(1):1-8. doi: 10.3111/13696990802648167. J Med Econ. 2009. PMID: 19450059 Free article.

7

Blinder MA, Vekeman F, Sasane M, Trahey A, Paley C, Duh MS. Blinder MA, et al. Among authors: vekeman f. Pediatr Blood Cancer. 2013 May;60(5):828-35. doi: 10.1002/pbc.24459. Epub 2013 Jan 17. Pediatr Blood Cancer. 2013. PMID: 23335275

8

Economic burden of brain metastases among patients with metastatic melanoma in a USA managed care population.

Vekeman F, Cloutier M, Yermakov S, Amonkar MM, Arondekar B, Duh MS. Vekeman F, et al. Melanoma Res. 2014 Dec;24(6):602-10. doi: 10.1097/CMR.0000000000000097. Melanoma Res. 2014. PMID: 24926818

9

Multicenter COMPACT study of COMplications in patients with sickle cell disease and utilization of iron chelation therapy.

Jordan L, Adams-Graves P, Kanter-Washko J, Oneal PA, Sasane M, Vekeman F, Bieri C, Magestro M, Marcellari A, Duh MS. Jordan L, et al. Among authors: vekeman f. Curr Med Res Opin. 2015 Mar;31(3):513-23. doi: 10.1185/03007995.2014.998815. Epub 2014 Dec 31. Curr Med Res Opin. 2015. PMID: 25495135

10

Age-Related Emergency Department Reliance in Patients with Sickle Cell Disease.

Blinder MA, Duh MS, Sasane M, Trahey A, Paley C, Vekeman F. Blinder MA, et al. Among authors: vekeman f. J Emerg Med. 2015 Oct;49(4):513-522.e1. doi: 10.1016/j.jemermed.2014.12.080. Epub 2015 Apr 21. J Emerg Med. 2015. PMID: 25910824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters